Taihe Weiye Biotechnology

Company Deals

Taihe Weiye Biotechnology Secures RMB 300 Million in Series A+ Financing to Expand Production

Fineline Cube Nov 29, 2023

Chengdu Taihe Weiye Biotechnology Co., Ltd, a Chinese developer of protected amino acids drugs, has...

Company Drug

Amgen’s Uplizna Approved by FDA for IgG4-Related Disease

Company Drug

J&J’s Rybrevant SC Formulation Approved by EC for NSCLC Treatment

Company Deals

TJ Biopharma Partners with Biogen on Felzartamab Phase III Studies in China

Company Drug

J&J’s Darzalex SC Formulation Approved for Newly Diagnosed Multiple Myeloma